Dr. Hudson has been a director of the Company since August 2005. He is the sole proprietor of G&M Princeton Associates a pharmaceutical commercial development practice. He served as Chief Executive Officer and President of DOV Pharmaceutical Inc. a biopharmaceutical company from June 2005 to July 2006. Dr. Hudson served as Vice Provost for Strategic Initiatives at the University of Pennsylvania from 2003 to June 2005. From 1995 to 2003 he served in several positions at Pharmacia Corp. including senior vice president of research and exploratory development senior vice president of emerging technology and commercial development and general manager and group vice president of ophthalmology. From 1988 to 1994 he worked at GlaxoWellcome (now GlaxoSmithKline plc) in several senior research positions including head of cancer metabolic and hyperproliferative disease and vice president for discovery research in which he headed the company’s genomics program.
Dr. Hudson received his bachelor’s degree in zoology with first class honors from the Imperial College of Science Technology and Medicine at the University of London in 1968. He received his doctorate in immunology from the Imperial College and Middlesex Hospital Medical School University of London in 1975. Dr. Hudson is also an associate of the Royal College of Science. |